This page shows the latest PBC news and features for those working in and with pharma, biotech and healthcare.
The additional payments are dependent on the success of setanaxib (GKT831), Genkyotex’s lead clinical candidate which is currently in development for PBC, a chronic liver disease caused by progressive destruction ... We believe Genkyotex's novel NOX
Meanwhile, the company has refocused its efforts on developing its two other major programmes, including the development of elafibranor in primary biliary cholangitis (PBC) and the commercial growth of its ... efforts on our two top priorities: the PBC
It is already approved for primary biliary cholangitis (PBC) under the Ocaliva trade name.
The phase 2b study of seladelpar was being studied in patients with non-alcoholic steatohepatitis ( NASH), and in a recently initiated phase 2 study in patients with primary biliary cholangitis (PBC). ... In light of the findings, we have decided to
These results were from non-cirrhotic patients with PBC, and with those who had inadequate response to ursodeoxycholic acid (UDCA), the current standard of care. ... In addition to significant reductions in ALP, those in both elafibranor-treated groups
$35m has been allocated to a phase 3 trial of elafibranor in primary biliary cholangitis (PBC), a rare autoimmune disease of the liver, and $6m will go towards developing a companion ... A phase 3 PBC trial is scheduled to start before the end of 2019.
More from news
Approximately 2 fully matching, plus 34 partially matching documents found.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
He also brings prior experience with Huntsworth Health, PBC Group and Root Research to the role.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
4. WHAT SETS OPEN HEALTH APART IN THE PR SPACE? At OPEN Health, PR sits within OPEN Health’s Patient and Brand Communications (PBC) division. ... OPEN Health PBC was created by the coming together of strong, iconic legacy healthcare agencies with deep
We’re No.1! PMLive have named OPEN Health Patient &Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those creative agencies who had the most impact in the UK healthcare
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly heart-warming service to children and their families at very tough times in
th. September. For more information contact:. Richard Jones, Managing Director – Patient Engagement OPEN Health PBC.
OPEN Health PBC recognised as No. 1 independent creative agency.
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...